Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profusa (PFSA) Research & Development (2024 - 2025)

Profusa filings provide 2 years of Research & Development readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 384.56% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a N/A change, with the full-year FY2025 number at $2.8 million, up 74.38% from a year prior.
  • Research & Development hit $1.3 million in Q4 2025 for Profusa, up from $722000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.3 million in Q4 2025 to a low of $259000.0 in Q4 2024.